Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ArthroCare Corporation Announces Q3 Earnings Conference Call.


Business Editors

SUNNYVALE, Calif.--(BUSINESS WIRE)--Oct. 29, 2002

ArthroCare Corporation (Nasdaq: ARTC ARTC Arthrocare Corp (stock symbol)
ARTC Australian Rail Track Corporation
ARTC Air Route Traffic Control
ARTC Association de la Recherche Theatrale au Canada
ARTC Andean Root and Tuber Crops
), a multi-business medical device company that develops products based on its patented Coblation(R) technology will hold its quarterly conference call to discuss third quarter results on Wednesday, October 30, 2002, at 6:00pm Eastern Time (3:00pm Pacific Time).

This call is being webcast by CCBN CCBN Central Coast Bancorp
CCBN Charles County Business Network
 and can be accessed at ArthroCare's web site at www.arthrocare.com.

The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

ArthroCare Corp. (www.arthrocare.com), headquartered in Sunnyvale, CA, is a multi-business medical device company that develops, manufactures and markets minimally invasive soft tissue surgical products based on its patented Coblation technology. Coblation uses low-temperature radio-frequency energy to gently and precisely dissolve rather than burn soft tissue, minimizing damage to healthy tissue. ArthroCare targets a multi-billion dollar market opportunity across several medical specialties Medical Specialties
See also anatomy; disease and illness; drugs; health; remedies; surgery.

adenography

the science of the description of glands. — adenographic, adj.
, significantly improving surgical procedures Surgical procedures have long and possibly daunting names. The meaning of many surgical procedure names can often be understood if the name is broken into parts. For example in splenectomy, "ectomy" is a suffix meaning the removal of a part of the body. "Splene-" means spleen.  and enabling new, minimally invasive procedures Minimally invasive surgical procedures avoid open invasive surgery in favor of closed or local surgery with less trauma. These procedures involve use of laparoscopic devices and remote-control manipulation of instruments with indirect observation of the surgical field through an . ArthroCare's Coblation-based devices have been used in more than 1.75 million surgical procedures worldwide. The company has developed and marketed Coblation-based products for arthroscopic, spine/neurologic, ear, nose and throat, cosmetic, urologic, gynecologic gynecologic /gy·ne·co·log·ic/ (gi?ne-) (jin?e-kah-loj´ik) pertaining to the female reproductive tract or to gynecology.  and laparoscopic/general surgical procedures, and continues research in other areas.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 29, 2002
Words:252
Previous Article:Milberg Weiss Announces Class Action Lawsuit Against NUI Corporation.
Next Article:C3i, Inc. Selected to Present at Fifth Annual CRM for the Pharmaceutical Industry Conference.
Topics:



Related Articles
ArthroCare Reports Third Quarter Results; Results Include Provisions For Strategic Initiatives.
Arthrocare Net Income Up 186 Percent in Fiscal 2000; Product Sales Driven By Strong Growth In Arthroscopy.
ArthroCare to Directly Distribute Cosmetic Surgery Products; Earnings Date Set; Stock Buy Back Program Approved.
ArthroCare to Announce First Quarter Financial Results April 18.
ArthroCare Reports 18 Percent Product Sales Growth in Third Quarter; Net Income Impacted by Manufacturing and Sales Investments.
ArthroCare Corporation Fourth Quarter 2002 Earnings Conference Call.
ArthroCare Announces Results of Annual Meeting of Stockholders; Company Reiterates Financial Guidance for Fiscal 2003.
ArthroCare To Hold Third Quarter 2003 Conference Call and Open the NASDAQ Stock Market.
ArthroCare's Third Quarter Product Revenues Rise 34 Percent to $28.6 Million; Net Income Grows 225 Percent Year-over-Year with EPS of $0.10.
ArthroCare Announces Preliminary Fiscal 2005 Financial Guidance.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles